Loading data for HLN — first visit, this takes a few seconds.
Haleon (HLN)
NYSE: HLN
· Real-Time Price · USD
9.87
+0.15 (1.54%)
At close: Aug 20, 2026, 8:00 PM
9.87
+0.00%
After-hours: 5:05 PM
The price, the headline numbers and the latest news, in one place.
Haleon (HLN) Stock Price, Analysis & Data
1.54% (1D)
No data available
| Bid | 9.87 |
| Market Cap | 43.41B |
| Revenue (ttm) | 11.15B |
| Net Income (ttm) | 1.62B |
| 0.24 | |
| 0.49 | |
| 20.14 | |
| 15.84 | |
| P/B (ttm) | 1.98 |
| P/S (ttm) | 3.89 |
| Earnings Date | Feb 24, 2027 |
| Ask | 9.92 |
| Volume | 11,337,180 |
| Avg. Volume (20D) | 9,524,391 |
| Open | 9.81 |
| Previous Close | 9.72 |
| Day's Range | 9.79 - 9.96 |
| 52-Week Range | 8.65 - 11.28 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.2 (2%) |
| Ex-Dividend Date | Aug 14, 2026 |
About HLN
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum...
Sector Healthcare
IPO Date Jul 25, 2022
Employees 24,535
Stock Exchange NYSE
Ticker Symbol HLN
Website https://www.haleon.com
Financial Performance
In 2025, Haleon's revenue was 11.03B, a decrease of -1.81% compared to the previous year's 11.23B. Earnings were 1.67B, an increase of 15.6%.
Financial StatementsEarnings Surprise
Haleon has released their quarterly earnings on Oct 31, 2024:
- Revenue of $2.76B misses estimates by $0, with Infinity% YoY growth.
- EPS of 0.12 exceeds estimates by 0.01, with 9.09% YoY growth.
Haleon is scheduled to release its earnings on Feb 24, 2027, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2